Literature DB >> 3791168

Necrobiotic xanthogranuloma with myeloma. A case report.

P Y Venencie, A Puissant, O Verola, Y Kerneis, C Marchat, P Le Bras, M F D'Agay, F Danon, F Valensi, G Turpin.   

Abstract

Necrobiotic xanthogranuloma is a newly recognized cutaneous manifestation associated with paraproteinemia. Necrobiotic xanthogranuloma is distinctive clinically by yellowish-red nodular lesions, often ulcerated, with predilection for the periorbital area and ocular involvement. Histologically, it is characterized by the combination of inflammatory xanthogranulomas together with areas of necrobiosis. These skin lesions are associated with a dysglobulinemia and preceded the development of an IgG lambda myeloma in a previous patient. Hyperlipidemia may be found in some patients. A case of necrobiotic xanthogranuloma is reported, occurring in a 46-year-old man and associated with an IgG kappa myeloma.

Entities:  

Mesh:

Year:  1987        PMID: 3791168     DOI: 10.1002/1097-0142(19870201)59:3<588::aid-cncr2820590339>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria.

Authors:  Caroline A Nelson; Connie S Zhong; David A Hashemi; Hovik J Ashchyan; Zoe Brown-Joel; Megan H Noe; Sotonye Imadojemu; Robert G Micheletti; Ruth Ann Vleugels; Karolyn A Wanat; Misha Rosenbach; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2020-03-01       Impact factor: 10.282

2.  Orbital xanthogranuloma in adults.

Authors:  G E Rose; B C Patel; A Garner; J E Wright
Journal:  Br J Ophthalmol       Date:  1991-11       Impact factor: 4.638

Review 3.  Systemic therapy of necrobiotic xanthogranuloma: a systematic review.

Authors:  Lisa Steinhelfer; Thomas Kühnel; Herbert Jägle; Stephanie Mayer; Sigrid Karrer; Frank Haubner; Stephan Schreml
Journal:  Orphanet J Rare Dis       Date:  2022-03-24       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.